S. 4491: Biodefense Diplomacy Enhancement Act

The Biodefense Diplomacy Enhancement Act aims to improve international collaboration in biodefense, biosecurity, and biotechnology among the United States and its allies. The key components of the bill include:

Enhancement of Diplomatic Engagement

The Secretary of State is tasked with advancing U.S. foreign policy to boost cooperation in biodefense and biosecurity with allies. This involves a range of activities designed to enhance collaboration in facing biological threats and ensuring the safety of biotechnology developments.

Policy Development

The Secretary of State will coordinate with various officials to promote biodefense policy within NATO, including:

• Advocating for prioritized policy development regarding biodefense, biotechnology, and biosurveillance.
• Evaluating opportunities to strengthen NATO's biodefense capabilities.
• Proposing amendments to NATO's policies on biological threats.
• Coordinating with other NATO members on implementing biological safety measures.
• Enhancing the capabilities of NATO forces to respond to biological attacks.
• Identifying opportunities for improving NATO’s biotechnology research and deployment.
• Promoting compliance with high safety and security standards in biological research by NATO members.

Cooperation with Allies

The Secretary of State is also responsible for initiating international cooperation in biotechnology and biosecurity with non-NATO allies. This cooperation includes:

• Identifying areas of collaboration with major non-NATO allies.
• Working with allied nations to create export control policies focused on biotechnological items that pose national security risks.
• Encouraging allies to follow high safety and security standards in biological research.
• Collaborating on global enforcement of the Biological Weapons Convention.

Development of Strategies

Two significant strategies will be developed:

• NATO Biodefense Strategy: This strategy assesses current cooperation with NATO in biodefense and biotechnology, identifies planning gaps, and makes recommendations for improvements in coordination and capability development.
• International Biotechnology, Biosecurity, and Biodefense Cooperation Strategy: This outlines proposals for enhancing cooperation with allies on security matters involving biotechnology and assesses the effectiveness of export control initiatives related to high-risk biological items.

Reporting and Briefing Requirements

The Secretary of State must submit a report on the developed strategies to congressional committees within 270 days of the law's enactment. An unclassified report is required, although a classified annex may be included if necessary. Additionally, a briefing will be provided to Congress regarding significant developments related to biotechnology and biosecurity within 90 days after the enactment.

Definitions

The bill outlines key definitions to clarify terms used within, including:

• Biodefense: Actions to counter biological threats and prepare for incidents.
• Biosecurity: Policies and practices to prevent the misuse of biological materials.
• Biosurveillance: Processes for early detection of biological threats.
• Biotechnology: Using biological processes for various purposes, including research and medical use.

Relevant Companies

None found.